Bach1 derepression is neuroprotective in a mouse model of Parkinson's disease.
Bach1 derepression is neuroprotective in a mouse model of Parkinson's disease.
复制标题
在帕金森病小鼠模型中,Bach1抑制具有神经保护作用。
DOI:
10.1073/pnas.2111643118
复制
发表时间:
2021-11-09
影响因子:
11.1
通讯作者:
Thomas B
中科院分区:
文献类型:
--
作者:
Ahuja M;Ammal Kaidery N;Attucks OC;McDade E;Hushpulian DM;Gaisin A;Gaisina I;Ahn YH;Nikulin S;Poloznikov A;Gazaryan I;Yamamoto M;Matsumoto M;Igarashi K;Sharma SM;Thomas B
The Keap1-Nrf2 signaling pathway is a promising therapeutic target for Parkinson’s disease (PD). Canonical Nrf2 activators targeting Keap1 thiols are known to be preventive but never effectively cure chronic neurodegeneration because of their electrophilic nature, resulting in nonspecific reactions with active cysteine residues in a variety of cellular proteins. We show that genetic and pharmacologic inhibition of the Nrf2 repressor Bach1 in a posttreatment regimen of experimental PD is neuroprotective by up-regulating Bach1-targeted pathways involving both Nrf2-dependent antioxidant response element (ARE) and non-ARE genes. Inhibition of Bach1 by a nonelectrophilic substituted benzimidazole is a promising therapeutic approach for PD. Parkinson's disease (PD) is a progressive neurodegenerative movement disorder characterized by the loss of nigrostriatal dopaminergic neurons. Mounting evidence suggests that Nrf2 is a promising target for neuroprotective interventions in PD. However, electrophilic chemical properties of the canonical Nrf2-based drugs cause irreversible alkylation of cysteine residues on cellular proteins resulting in side effects. Bach1 is a known transcriptional repressor of the Nrf2 pathway. We report that Bach1 levels are up-regulated in PD postmortem brains and preclinical models. Bach1 knockout (KO) mice were protected against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity and associated oxidative damage and neuroinflammation. Functional genomic analysis demonstrated that the neuroprotective effects in Bach1 KO mice was due to up-regulation of Bach1-targeted pathways that are associated with both Nrf2-dependent antioxidant response element (ARE) and Nrf2-independent non-ARE genes. Using a proprietary translational technology platform, a drug library screen identified a substituted benzimidazole as a Bach1 inhibitor that was validated as a nonelectrophile. Oral administration of the Bach1 inhibitor attenuated MPTP neurotoxicity in pre- and posttreatment paradigms. Bach1 inhibitor–induced neuroprotection was associated with the up-regulation of Bach1-targeted pathways in concurrence with the results from Bach1 KO mice. Our results suggest that genetic deletion as well as pharmacologic inhibition of Bach1 by a nonelectrophilic inhibitor is a promising therapeutic approach for PD.
登录
查看更多内容
影响因子:
3.5
作者:
Kaidery, Navneet Ammal;Ahuja, Manuj;Thomas, Bobby
通讯作者:
Thomas, Bobby
影响因子:
4.8
作者:
Hushpulian DM;Ammal Kaidery N;Ahuja M;Poloznikov AA;Sharma SM;Gazaryan IG;Thomas B
通讯作者:
Thomas B
影响因子:
64.8
作者:
Lee, Jiyoung;Yesilkanal, Ali E.;Rosner, Marsha Rich
通讯作者:
Rosner, Marsha Rich
影响因子:
3.7
作者:
Attucks OC;Jasmer KJ;Hannink M;Kassis J;Zhong Z;Gupta S;Victory SF;Guzel M;Polisetti DR;Andrews R;Mjalli AM;Kostura MJ
通讯作者:
Kostura MJ
DOI:
10.1126/science.aan4665
发表时间:
2018-04-27
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Kornberg MD;Bhargava P;Kim PM;Putluri V;Snowman AM;Putluri N;Calabresi PA;Snyder SH
通讯作者:
Snyder SH